In.vision Research Corporation and netNumina announced the launch of a cooperative effort to bring the benefits of XML authoring and Service Oriented Architecture (SOA) to the biopharmaceutical industry. Xpress Author for Microsoft Word allows biopharmaceutical professionals to author documents in a Word environment without concern for the technical complexity of XML. In most cases the actual authoring is made easier than before by automatically pulling in required text objects as standard text. While this improves authoring and reuse of information, it also allows for structured XML information to be automatically extracted from these documents for use in portals, workflow and performance measurements. The following customized implementations of Xpress Author for Microsoft Word are targeted for the biopharmaceutical industry: Clinical program and clinical trial protocols, Pharmaceutical Product Labeling, Biopharmaceutical Research Documentation, and Manufacturing and Process Documentation. www.invisionresearch.com, www.netnumina.com

Share